Identification of METTL3 as an Adverse Prognostic Biomarker in Hepatocellular Carcinoma
Sign Up to like & getrecommendations! Published in 2020 at "Digestive Diseases and Sciences"
DOI: 10.1007/s10620-020-06260-z
Abstract: N6-methyladenosine (m6A), the most prominent mRNA modification, plays a critical role in many physiological and pathological processes. However, the roles of m6A RNA modification in hepatocellular carcinoma (HCC) remain largely unknown. We investigated the mRNA… read more here.
Keywords: hepatocellular carcinoma; identification mettl3; carcinoma; m6a related ... See more keywords